Epalinges, Switzerland · Founded 2021 · Privately Held (backing)
Operator of a global cancer real-world data platform designed to enable molecular testing and AI-driven insights for improved cancer care outside the US. Hedera Dx is based in Epalinges, Switzerland and was founded in 2021. Its last reported valuation was $43 million in Mar 2024. It has raised $36.8 million.
Last reported valuation
$43.0M
Oct 2026
Priced at
—
Total raised
$36.8M
Last round
—
Cap table — not yet on record
Hedera Dx's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Hedera Dx with a free account
·The complete investor list: 11 names
·Watch Hedera Dx: the Monday email on marks, rounds and moves
